Reata Pharmaceuticals has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.
View Top Employees from Reata Pharmaceuticals, Inc.Website | https://www.reatapharma.com/ |
Ticker | NASDAQ:RETA |
Revenue | $48 million |
Funding | $824 million |
Employees | 391 (391 on RocketReach) |
Founded | 2002 |
Address | 5320 Legacy Dr Bldg 2, Plano, Texas 75024, US |
Phone | (972) 865-2219 |
Technologies |
JavaScript,
HTML,
Twitter
+57 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Biopharma, Biopharmaceuticals, Healthcare, Drug Discovery, Research, Health Care, Clinical Operations, Science and Engineering, Pharmaceutical |
Web Rank | 2 Million |
Keywords | Biotechnology, Pharmaceutical Research, Biopharmaceuticals, Drug Development And Manufacturing, Neurodegenerative Diseases |
Competitors | Acceleron Pharma, Affectis Pharmaceuticals, Otonomy, Inc, Proteostasis Therapeutics, Inc. (PTI), Xenon Pharmaceuticals Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Reata Pharmaceuticals, Inc. employee's phone or email?
The Reata Pharmaceuticals, Inc. annual revenue was $48 million in 2024.
Brian Walls is the Vice President, Market Access of Reata Pharmaceuticals, Inc..
391 people are employed at Reata Pharmaceuticals, Inc..
Reata Pharmaceuticals, Inc. is based in Plano, Texas.
The NAICS codes for Reata Pharmaceuticals, Inc. are [3254, 32541, 32, 325].
The SIC codes for Reata Pharmaceuticals, Inc. are [873, 87].